BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180307
DTEND;VALUE=DATE:20180309
DTSTAMP:20260515T083509
CREATED:20171212T070945Z
LAST-MODIFIED:20171212T070945Z
UID:5264-1520380800-1520553599@www.pharmajournalist.com
SUMMARY:Clinical Trial Supply New England
DESCRIPTION:The 7th Annual Clinical Trial Supply New England is back in 2018 on the 7th-8th March for what promises to be a fantastic event. The perfect event for all biotech’s and pharma companies in the New England region to come together and explore the latest issues\, trends and technologies within the clinical supply world. \nUnderstanding the characteristics of the region\, we have created a two days conference with full of sessions that will be an interest of smaller pharma and biotechs. It is all geared up with fresh up-to-date topics that you can learn from how your peers in the industry are managing the challenges and seek for new strategies from thought-provoking discussions. \nHere is the preview of two key topics for the 2017 event. \nImport and export regulation \nNo one likes getting unexpected bills. So do you. Marco Afonso\, Supervisory Import Specialist at U.S. Customs and Border Protection will be presenting a detailed exploration the evolving landscape of importing clinical trial materials and products into the US specifically investigating the key facts all companies should know when importing to the US to clarify your obligations to tax\, VAT and regulatory transgressions. \nContingency planning for natural disasters \nAs climate change worsens and typical weather patterns are altered resulting in unforeseen natural phenomena it is paramount of the industry to be able to react in a quick\, seamless manager when typical supply chain routes are disrupted. Chad Presher\, Associate Director\, Clinical Drug Supply\, Biogen will be presenting a case study which will among other things\, focus on the implications of hurricane Harvey on clinical trials to better prepare responses to ensure trial supply reaches the site
URL:https://www.pharmajournalist.com/event/clinical-trial-supply-new-england/
LOCATION:Boston\, MA
ORGANIZER;CN="Arena International":MAILTO:Events@arena-international.com
END:VEVENT
END:VCALENDAR